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ABSTRACT 
 
 
ABID KHAN. Regulation of Myc and its localization to Histone Locus Body in 
Drosophila. (Under the direction of DR. JULIE GOODLIFFE) 
 
Myc is a transcriptional factor required for normal growth and development in 
vertebrates and invertebrates alike. Loss of function mutations in Myc can cause 
embryonic lethality in mammals and larval death in flies whereas an increase in its 
activity can lead to tumorigenesis. Therefore, proper regulation of Myc is very important 
to ensure normal development. Regulation of Myc occurs by several context specific 
mechanisms. One such mechanism is the negative feedback autoregulation of Myc and 
this mechanism is lost in all tumorigenic cell lines. Like its mammalian homolog, the 
Drosophila Myc (dMyc) undergoes autoregulation in the presence of an ectopic myc 
gene leading to a Myc null phenotype. Polycomb (Pc), a chromatin binding repressor is 
required for Myc autoregulation. Upon Pc knockdown, levels of Su(z)2, a Pc group 
related protein increase significantly, suggesting that Pc represses Su(z)2. We show here 
that ectopic Su(z)2 can interfere with Myc autorepression and restore endogenous Myc 
levels as well as rescue larval lethality caused due to Myc autorepression. Su(z)2 does not 
however, affect general repression by Myc suggesting that repression of myc locus 
occurs by a different mechanism. During this study we observed that Myc protein forms 
distinct puncta in certain tissues. Upon investigating we found that these Myc ―spots‖ 
localize to sub-nuclear organelles known as Histone Locus Body (HLB). HLBs are 
histone pre-mRNA processing centers formed at histone gene locus. We show here that 
Myc localizes to the HLBs only during S phase. Since hisones are transcribed only during 
S phase we hypothesize that Myc aids in histone transcription, a novel role for Myc.  
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CHAPTER 1: INTRODUCTION 
 
 
Drosophila Myc (dMyc), like its mammalian homolog, c-Myc, is a transcriptional 
factor belonging to the basic helix-loop-helix-zipper (bHLHZ) family of proteins. It binds 
to and regulates the expression of several genes required for normal development. Its 
target genes are involved in important cellular functions such as protein synthesis, 
metabolism, riobosomal biogenesis, growth and proliferation to. Hence, deregulation in 
Myc activity can lead to a wide variety of human cancers (Secombe, Pierce et al. 2004; 
Eilers and Eisenman 2008). In this section we will discuss the molecular basis of dMyc 
activity, its regulation during development and the physiological consequence of 
deregulation of its expression.  
1.1 Myc as a transcriptional factor: 
Myc protein consists broadly of two major domains: the C terminal containing a 
dimerization/DNA binding domain required for DNA binding via heterodimerization 
with its partner Max and the N terminus transactivation domain. Deletion of the 
dimerization domain causes loss of its biological activity suggesting that binding to DNA 
via dimerization with Max is essential for its function (Stone, de Lange et al. 1987; Dang, 
McGuire et al. 1989; Blackwood, Lüscher et al. 1992). The Myc-Max heterodimer 
recognizes and binds to a consensus sequence CACGTG known as the E box at the 
promoter of its target gene. The transactivation domain (TAD) of Myc is required for the 
transcriptional activation of its target gene (Amati, Dalton et al. 1992). Unlike Myc, Max 
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lacks a TAD but is required by Myc for sequence specific DNA binding. Although the 
Myc-Max dimer is a relatively weak activator of transcription, the TAD coupled to a 
GAL4 DNA binding domain can activate transcription 20-200 fold higher (Brough, 
Hofmann et al. 1995).  
As a transcriptional activator, Myc-Max dimer interacts with other cofactors such 
as TRRAP, which then recruits histone acetyl transferases (HAT) such as GCN5 
(McMahon, Van Buskirk et al. 1998; McMahon, Wood et al. 2000). The HAT acetylates 
the histones at the promoter leading to the transcriptional activation of the target gene. 
Myc is also known to associate with other cofactors such as Tip60 Lid/Rbp2 H3-K4 
demethylase, HectH9 ubiquitin ligase, etc., required to modify chromatin to aid in gene 
activation (Adhikary and Eilers 2005; Cole and Nikiforov 2006; Secombe, Li et al. 2007).  
Figure 1: A schematic representation of the mechanism of transcriptional activation by 
Myc.  
 
On the contrary, transcriptional repression by Myc is rather indirect. Mycis 
known to bind and inhibit the function of the transcription factor Miz1, leading to the 
 3 
repression of Miz1 activated targets such as p15 and certain Cdk inhibitors(Staller, 
Peukert et al. 2001). 
In contrast to Myc, Max can associate with other bHLHZ proteins known as the 
Mxd protein family and Mnt. Unlike Myc-Max dimers which cause transcriptional 
activation, the Mxd-Max heterodimer binds to E box and represses transcription by 
associating with the Sin3 corepressor complex which consists of histone deacetylases 
(HDACs)(Gallant, Shiio et al. 1996; Schreiber-Agus and DePinho 1998). Mnt behaves 
asantagonist to Myc in developmental context (Loo, Secombe et al. 2005). Conditional 
deletion of Mnt in breast epithelium causes tumorigenesis and cells depleted for Mnt by 
RNAi phenocopy cells that overexpress Myc (Hurlin, Zhou et al. 2003; Hooker and 
Hurlin 2006). In Drosophila Mnt mutation can partially rescue Myc null mutant 
phenotype(Pierce, Yost et al. 2008).   
1.2 Biological Functions of Myc:  
Myc is essential for normal growth and development in vertebrates and 
invertebrates alike with the exception of nematodes. Mice that are homozygous null for c-
myc do not survive past 9.5 days of embryogenesis (Davis, Wims et al. 1993). Flies with 
a hypomorphic mutation have abnormally small body size whereas a null mutation causes 
larval lethality(Johnston, Prober et al. 1999). Myc was recently identified as one of the 
four key factors required to induce pluripotency in a somatic cell to produce an 
embryonic stem cell like state, suggesting that Myc is very important for early 
embryogenesis (Takahashi and Yamanaka 2006).  
As a transcription factor Myc controls the expression of a large number of genes. 
It is shown to be associated with 10%-15% of genomic loci in both mammals and 
 4 
Drosophila (Fernandez, Frank et al. 2003; Orian, van Steensel et al. 2003). The bound 
loci represent genes with a broad range of functions including ribosome biosynthesis, 
protein translation, metabolism, and cell cycle regulation.   
Similar to mammalian Myc, Drosophila Myc (dMyc) is a positive regulator of 
growth and proliferation. It is capable of transforming primary mammalian cells and 
rescuing the proliferation defects in c-myc null fibroblasts (Schreiber-Agus, Stein et al. 
1997). In the wing imaginal discs of Drosophila, dmyc mutation causes smaller cell size 
without affecting the cell cycle distribution. Overexpression of dmyc resulted in larger 
cells without any change in cell division rate (Johnston, Prober et al. 1999). The 
regulation of cellular growth without changes in cell division rate suggests that Myc 
regulates components of cell growth machinery. This is achieved in part by regulating 
genes involved in ribosome biogenesis, protein translation and metabolism (Orian, van 
Steensel et al. 2003).  
Most of the genes regulated by Myc are transcribed by RNA polymerase II but 
there is evidence that Myc can induce activation of genes transcribed by RNA 
polymerase I and III (Grewal, Li et al. 2005; Steiger, Furrer et al. 2008). The genes 
transcribed by RNA polymerase I and III make up the translation machinery (rRNAs and 
t-RNA). While c-Myc is known to bind to rDNA loci and activate transcription of 
ribosomal RNA, dMyc does not physically occupy these loci but is required for the 
induction of these genes in an RNA polymerase I dependent manner (Grandori, Gomez-
Roman et al. 2005; Grewal, Li et al. 2005).  
Recently it has been shown that Myc acts downstream of target of rapamycin 
(TOR) and insulin receptor (InR) pathways to promote cell growth in a nutrient 
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availability dependent manner (Teleman, Hietakangas et al. 2008; Li, Edgar et al. 2010). 
Myc is also required for endoreplication in larval salivary gland cells (Pierce, Yost et al. 
2004). These cells can reach ploidy of up to 1000n and make up most of the larval mass. 
Myc is known to regulate cell cycle progression in the endoreplicating cells. Mutations in 
dmyc cause cells to stall in G1 whereas overexpression can accelerate the G1-S transition 
(Maines, Stevens et al. 2004; Pierce, Yost et al. 2004). Although Myc is not essential for 
cell cycle progression, it is thought that Myc increases the frequency of S phase in 
endoreplicating cells by increasing the stability and hence activity of CycE/Cdk2.  
One of the unique functions of Myc, which is not common to other growth factors, 
is induction of cell competition. It is a phenomenon by which cells with high levels of 
Myc protein out compete and kill the neighboring cells with relatively low levels of Myc. 
The cells overexpressing Myc can grow faster than their wildtype neighboring cells 
which eventually undergo apoptosis and are eliminated (de la Cova, Abril et al. 2004; 
Moreno and Basler 2004). It is thought that cell competition could contribute to an 
overall organ size control mechanism. 
1.3 Regulation of dMyc expression: 
Although Myc is widely studied for its role in growth and proliferation, 
surprisingly there is not much data about the regulation of dmyc gene in comparison to 
the function of the protein. This is probably because regulation of dmyc is a highly 
dynamic and a very context specific process that involves different regulators in a 
spatiotemporal dependent manner. In the growing wing imaginal discs, Myc is expressed 
throughout the organ but is later lost in the zone of non-proliferating cells (ZNC) due to 
the activity of wingless (Wg). Wg represses dmyc expression in the ZNC (Johnston and 
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Edgar 1998; Johnston, Prober et al. 1999). The inhibition of dmyc by Wg could be 
through half-pint (Hfp), a homolog of human FBP interacting repressor (FIR), a pre-
mRNA splicing factor also called PUF60. Hfp mutants have elevated dmyc transcripts 
and ZNC fails to form(Quinn, Dickins et al. 2004).The Hippo pathway is also known to  
 
 
Figure 2: Regulation of dMyc expression at the transcript and protein level. Arrow 
denotes activation and the perpendicular lines denote repression. Hfp, Wg and GSK3β 
repress Myc whereas Yki activates dMyc expression 
 
 
regulate dmyc expression in the growing wing. Yorkie (Yki), the downstream effector of 
the pathway and Myc work in negative feedback regulatory mechanism. Yki, directly 
activates dmyc transcription, whereas high levels of Myc repress Yki in a transcriptional 
and post-transcriptional mechanism (Neto-Silva, de Beco et al. 2010; Stocker 2011). The 
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dMyc protein has a short half-life and its stability can be regulated by GSK3β which 
phosphorylates Myc, marking it for degradation (Bellosta and Gallant 2010).  
1.4 Myc Autoregulation: 
Myc expression is vital during the proliferative period of a cell, whereas when 
cells start to differentiate, Myc levels start to drop accordingly and remain at a basal level 
after terminal differentiation. This is important to prevent uncontrolled proliferation of 
cells and to ensure normal differentiation during development. Understanding how cells 
achieve a tightly orchestrated temporal Myc expression program is important to 
understand Myc induced tumorigenesis. Culture cells with a constitutively active ectopic 
c-myc gene undergo an auotoregulatory mechanism and switch off the expression of the 
endogenous myc gene. The expression is inhibited at the transcriptional initiation step 
and requires additional trans-acting cofactors (Penn, Brooks et al. 1990). The extent of 
the endogenous c-myc silencing was found to be proportional to the Myc protein levels in 
the cells. Interestingly, all tumorigenic cell lines with an ectopic myc gene were defective 
in autoregulation, whereas cell lines with intact Myc autorepression mechanism were not 
tumorigenic when implanted into nude mice (F Grignani 1990; Facchini, Chen et al. 
1997).  
 Like its mammalian homolog, the Drosophila myc gene also undergoes 
autorepression in the presence of an ectopic myc gene. Interestingly, a chromatin binding 
repressor Polycomb (Pc) was identified in a screen performed to isolate repressors of 
dmyc transcription. In vivo experiments demonstrated that Pc is required for dmyc 
autorepression and also for Myc induced transcriptional repression of other loci 
(Goodliffe, Wieschaus et al. 2005).  Upon Pc knockdown, dmyc autorepression is 
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abrogated and 73% of dmyc repression targets are derepressed, suggesting that in general, 
Myc induced repression of its own locus as well as other repression targets requires the 
presence of Pc. If Pc is involved directly in repressing these loci, then depletion of other 
Polycomb Group (PcG) members that are required for Pc activity should produce similar 
if not same results as with Pc knockdown. However, the knockdown of Pho, a protein 
required to recruit Pc to the repression targets, does not affect Myc autorepressioin 
(Goodliffe, Wieschaus et al. 2005). Therefore, we hypothesize that the role of Pc in dmyc 
autorepression is rather indirect. Pc is required to repress another gene(s) which can 
interfere with dmyc expression. In this study we investigate the role of Pc and a PcG 
related protein, Su(z)2 in Myc autoregulation during embryogenesis.   
1.5 Polycomb Group (PcG): 
 PcG is a multi-protein transcriptional repressive complex required for the 
maintenance of cellular transcriptional memory throughout development. PcG proteins 
are best known for their role in the spatial regulation of Hox genes, demonstrated by the 
fact that mutations in PcG members can cause homeotic transformations (Kennison 1995; 
Beuchle, Struhl et al. 2001). In addition to Hox gene regulation, PcG is known for its role 
in cell cycle control, cancer, X-inactivation, cell fate decisions and stem cell 
differentiation (Wang, Mager et al. 2001; Sparmann and van Lohuizen 2006; Pasini, 
Bracken et al. 2007).  
 1.6 Recruitment of PcG complexes: 
 PcG proteins work in two separate multi-protein complexes: Polycomb repressive 
complex 1 (PRC1), which contains Polycomb (Pc), Polyhomeotic (PH), Posterior sex 
combs (PSC) and RING (Francis, Saurin et al. 2001; Saurin, Shao et al. 2001). Polycomb 
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Repressive Complex 2 (PRC2) which contains extra sex combs (ESC), Enhancer-of-
zesteE(Z), the suppressorof position effect variegation (PEV) SU(var)12(Brown, Mucci 
et al. 1998; Muller, Hart et al. 2002; Brown, Fritsch et al. 2003).A third complex, PhoRC, 
has been identified which contains the sequence specific DNA binding protein 
Pleiohomeotic (Pho) which is required to recruit other PcG components (Klymenko, Papp 
et al. 2006). 
 PcG proteins are recruited to specific DNA sequences known as the Polycomb 
response elements (PRE) (Ringrose, Rehmsmeier et al. 2003). PREs can be located 
anywhere from the proximal promoter to a few kilobases (kb) away from the 
transcription start site (TSS). These elements contain sequences recognized by different 
transcription factors such as Pho, Pho-l, and GAGA factor that then recruit other PcG 
proteins (Ringrose and Paro 2007). Upon binding to the PRE, Pho then recruits other 
members of the PRC2 complex.E(z), a component of PRC2, contains a SET domain that 
catalyzes the di and tri-methylation of histone H3 lysine 27(H3K27) at the locus. Pc 
contains a chromodomain which recognizes and binds to methylated H3K27.  
Although this mechanism seems logical, PcG recruitment is much more complex 
than this. First, Pho is not only able to recruit PRC2 but can also bind PRC1 components 
like Pc and Ph in-vitro (Mohd-Sarip, Cleard et al. 2005). Also, Pho binding sites alone 
are insufficient in recruiting PcG proteins to DNA in vivo. In Drosophila, Pho mutants 
are lethal in late developmental stage, and in mutant salivary glands lacking Pho, PcG 
proteins occupy most of their target loci on polytene chromosomes suggesting that 
recruitment PcG complexes can be mediated by other proteins in the absence of 
Pho(Brown, Fritsch et al. 2003).  
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 1.7 Mechanism of transcriptional repression by PcG complex: 
 Although there is a great deal of evidence regarding the biochemical properties of 
the PcG complexes, there isn’t a unanimous mechanism of transcriptional repression in 
vivo. PcG complexes have been shown to act in multiple ways to induce transcriptional 
repression. Firstly, the Drosophila PRC1 complex is shown to induce chromatin 
compaction in vitro (Francis, Kingston et al. 2004), however, there is no evidence of such 
compaction in vivo. PcG proteins do not localize to DNA dense regions in plants or 
animals, suggesting that PcG complexes do not induce compaction in vivoand that 
repression is caused by a mechanism other than chromatin compaction (Köhler and Villar 
2008).Second, the role of mono-ubiquitination of histone H2A lysine 119 (H2AK119) 
inPRC1 mediated repression is not well understood. Loss of this ubiquitination marks 
causes depression of PcG targets(Schwartz and Pirrotta 2007). It is suggested that 
ubiquitination limits the processivity of RNA Pol II, thereby causing transcriptional 
inhibition. PcG binding negatively correlates with RNA Pol II binding; however many 
PcG targets are expressed even when bound by PcG complex (Bracken, Dietrich et al. 
2006; Schwartz, Kahn et al. 2006). This suggests that RNA Pol II occupancy does not 
affect transcriptional repression. In another study it has been shown that PcG does not 
affect RNA Pol II binding but rather interferes with the transcriptional initiation (Dellino, 
Schwartz et al. 2004). Another possibility is that the presence of H3K27Me3 marks 
inhibits the deposition of activation marks at these loci; however, in embryonic stem cells, 
many genes contain activation as well as repression marks, known as ―bivalent domains‖ 
(Bernstein, Mikkelsen et al. 2006). These genes are bound by RNA Pol II and held in 
check by ubiquitination of H2A and poised for either activation or  
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Figure 3: A schematic of the PcG complexes and their mode of action in transcriptional 
repression 
 
 
repression depending on the context(Stock, Giadrossi et al. 2007). Lastly, there is 
growing evidence demonstrating the role of RNA interference (RNAi) machinery in PcG 
mediated repression. Studies have shown that the RNAi pathway is required for pairing-
sensitive-silencing (PSS), a phenomenon by which PREs tend to pair up from different 
regions of the same chromosome or from different chromosomes. In contrast however, a 
recent study shows that insulators and not PREs are required for long distance 
interactions between Pc targets(Li, Müller et al. 2011). RNAi machinery does not affect 
PcG recruitment but rather the establishment and/or maintenance of long distance 
contacts between PREs (Grimaud, Bantignies et al. 2006).  
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1.8 Supressor of Zeste 2 [Su(z)2]:   
Su(z)2 is a transcriptional repressor and a PcG related protein, homologous to 
PSC, a member of PRC1 complex. Overexpression of either of these genes causes 
abnormalities in sensory bristle development (Brunk, Martin et al. 1991; Sharp, Martin et 
al. 1994) suggesting a common functional relationship. At the molecular level, Su(z)2 
shares a 200 amino acid homology, known as homology region (HR domain) with PSC in 
which they are 37% identical, and a large (more than 1100 amino acids) C-terminal 
region which lacks sequence identity but has similar amino acid contents (similar amino 
acids region, SAACR)(Brunk, Martin et al. 1991). The HR domain is also similar to the 
HR domains of two mammalian proteins, Mel-18 and Bmi-1. Bmi-1 is a PcG protein in 
mammals which co-operates with Myc in tumorigenesis,(van Lohuizen, Verbeek et al. 
1991) whereas Mel-18 acts as a tumor suppressor by repressing Bmi-1 and Myc (Guo, 
Datta et al. 2007).  
The HR domain provides for the sequence specific DNA binding of these proteins 
and is evolutionarily conserved, whereas the SAACR domain is responsible for 
transcriptional repression. When targeted to a reporter gene promoter in mammalian cells, 
LexA fusion constructs of SAACR domain of Su(z)2 can be strong transcriptional 
repressors (Bunker and Kingston 1994). Although Su(z)2 is not part of the PcG 
complexes, it shares common targets with PSC, suggesting a degree of functional 
redundancy. Deletion of the Psc-Su(z)2 locus causes hyperproliferation (Classen, Bunker 
et al. 2009) in imaginal discs but deletion of either of them in mitotic clones has no 
phenotype, suggesting that they can compensate for each other (Beuchle, Struhl et al. 
2001). Through a series of biochemical experiments, it has been shown that PSC and 
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Su(z)2 are functional homologs and that Su(z)2 can replace PSC in a functional PRC1 
complex in-vitro (Lo, Ahuja et al. 2009). In addition to this, it can inhibit Swi/Snf 
mediated chromatin remodeling and cause chromatin compaction like other PcG proteins.  
1.9 Cajal Body and Histone Locus Body:  
Cajal Bodies (CB) are named after the Nobel laureate Ramon y Cajal who 
discovered them as small round body in the nuclei of nerve cells and called them 
accessory bodies. Coilin was identified to be a signature marker of these bodies (Andrade, 
Chan et al. 1991).  Although coilin is an important component of the CB, the biochemical 
functions of the protein are not well understood. It interacts with Lsm10 and Lsm11, 
components of the U7snRNPs (small nuclear Ribonuclearprotein), suggesting a role in 
RNA processing (Nizami, Deryusheva et al. 2010). Coilin is required for CB formation. 
Homozygous coilin knockout mice die as embryos; the adults that do survive have 
fertility and fecundity defects (Walker, Tian et al. 2009). In Drosophila however, 
homozygous mutants are perfectly viable with no phenotypic defects. Cells of these adult 
flies, lack CBs (Liu, Murphy et al. 2006; Liu, Wu et al. 2009).  
 Histone Locus Bodies (HLB) were discovered in Xenopus laevis oocytes  and 
were thought to be a subset of CBs. Recently, Liu and others showed, using two different 
probes (U85sca (CB-specific RNA) and U7snRNP) thought to be specific to CB, that the 
U7snRNP localizes to multiple foci. Surprisingly, they found that the U85sca and 
U7snRNA label two distinct nuclear bodies. The U85sca containing organelle was 
designated as CB because of the presence of other CB specific markers whereas the 
U7snRNP containing body was named HLB because of its association with the histone 
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gene locus (Liu, Murphy et al. 2006). HLBs were also identified later in cultured 
mammalian cells (Ghule, Dominski et al. 2008).  
HLBs and CBs can lie very closely to or even touch one another in many nuclei 
and coilin is found in both CBs and HLBs. (Daneshvar, Khan et al. 2011). The main 
function of HLB is replication dependent histone gene transcription and processing of 
histone pre-mRNA(White, Leslie et al. 2007). The U7 snRNP forms an important part of 
the HLB and is required for histone pre-mRNA processing. The histone mRNA, unlike 
other mRNAs, is not polyadenylated at its 3’ end and also does not have introns. The 3’ 
carries a stem loop extension that is cleaved prior to export to the cytoplasm. The 
endonucleolytic cleavage requires the U7snRNA which binds to the histone downstream 
element and stem-loop binding protein (SLBP) via Lsm10 and Lsm11, two protein 
components of U7snRNPs (Godfrey, Kupsco et al. 2006; Marzluff, Wagner et al. 2008; 
Godfrey, White et al. 2009). Many other proteins have been recently detected in the 
HLBs including FLASH, a protein required for histone pre-mRNA processing, NPAT, a 
transcription factor involved in histone gene expression, and symplekin, stem-loop 
binding protein (SLBP).  
Using the MPM2 antibody that recognizes a phospho epitope in HLB foci in cells 
undergoing S phase or cells with active Cyclin E/Cdk2, White and others identified two 
novel components of HLBs in Drosophila and showed that HLB assembly occurs 
through a hierarchical assembly process. Mxc, a homolog of the mammalian NPAT was 
identified to be essential for the HLB assembly along with Spt6, a transcription 
elongation factor(White, Burch et al. 2011). Mxc is required for histone gene 
transcription and processing. Although HLBs can form independent of histone gene 
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transcription, the integrity of such HLBs is compromised and without histone mRNA, the 
primitive HLBs formed at the histone locus soon disintegrate. Therefore, histone mRNA 
is required for the proper assembly and function of HLBs. 
 
 
 
 
 
 
CHAPTER 2: MATERIALS AND METHODS 
 
 
2.1 Fly Stocks, husbandry and Genetics: 
w[*]; P{w[+mW, hs]=Gal4-da.G32}UH1 
w[*]; P{w[+mW, hs]=Gal4-arm.S}11 
w[1118]; P{w[+mC]=UAS-dm.Z}132 
P{ry[+t7.2]=hsFLP}22, y[1] w[*]; P{w[+mC]=UAS-dm.Z}42 
P{XP}Su(z)2d01221 
w[*]; Su(z)2XP; UAS dmyc 
Oregon-R 
UAS-Lsm11-EYFP 
w
1118
; Df(2L)ED1196, P{3'.RS5+3.3'}ED1196/SM6a 
UAS-let-7/GFP 
Stocks were maintained at 18
o
C. Expression of transgene was induced by crossing to a 
Gal4 driver.   
2.2 RNA isolation: 
Embryos were collected on grape agar plates with yeast. Embryos were dechorionated 
with 50% sodium hypochlorite solution for 2 minutes and washed with water several 
times. Total RNA was isolated using TRIzol (Invitrogen). Embryos were homogenized in 
TRIzol and phenol-chloroform was added to separate the aqueous solution from the 
organic. RNA was precipitated using sodium acetate and ethanol. RNA samples DNAse 
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treated and tested for quality and concentration using NanoDrop spectrophotometer prior 
to RT-PCR. 
2.3 RT-PCR: 
             For semi-quantitative RT-PCR, we used AccessQuick RT-PCR system 
(Promega) to amplify target transcripts from RNA, and quantified band intensities using 
Quantity 1 (Bio-Rad). PCR cycles were minimized to examine expression changes within 
the linear range (24–25 cycles, depending on the primer set). For all experiments, RNA 
was extracted from 0-21 hrs of embryo collection. Endogenous dmyc expression was 
assayed using a primer set that amplifies the 5′ untranslated region (UTR) of dmyc, 
which is absent in the UAS dmyc transgene. To amplify ectopic myc expression, we used 
a primer that binds to the 9E10 epitope tag present on the transgenic transcript. All 
experiments were done in biological triplicates, with no more than 25 PCR cycles. For 
qRT-PCR, we used Power SYBR® Green RNA-to-CT™ 1-Step Kit and ABI 7500 Fast 
real-time PCR system (Applied Biosystems, California, USA) to quantify mRNA 
transcripts.  Comparative Ct method was used for quantification of all mRNA transcripts. 
Ras64B was used as internal reference gene for quantification. 
 
2.4 Chromatin Immunoprecipitation (ChIP): 
             ChIP was performed as described previously (Goodliffe et al., 2005). Briefly, a 
collection of 0-24 hours old embryos were dechroniated in bleach and fixed in 3.7% 
formaldehyde in PBS/Heptane and sonicated in SDS-lysis buffer. The EZ-ChIP kit 
(Millipore, Massachusetts, USA) was used for precipitation and washes. Antibodies were 
used at a concentration of 1:100. Precipitated DNA was used as template for PCR 
amplification using GoTaq Hot-Start polymerase (Promega), and band intensities were 
quantified using Quantity 1 (Bio-Rad). Anti-H3K27-3Me is obtained from Millipore, 07-
449. Anti-MycN antibodies (SantaCruz Biotechnology, sc-28208) 
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2.5 Tissue fixation and Immunostaining:  
            Embryos were fixed in formaldehyde/PBS, and stained using 1:500 concentration 
of antibody in PBS/0.1% Triton X-100/5% BSA. Other tissues were also fixed in 
formaldehyde/PBS; permeabilized and stained in TritonX/PBS/BSA. For the validation 
of the co-localization spots we performed several control experiments. We stained Myc 
primary with the right secondary; Myc primary with individual wrong secondary 
antibody; Myc primary with all secondary antibodies. We eliminated the secondary 
antibody that showed cross-reactivity to Myc primary. For microscopy we used 
sequential scanning of each channel, ensuring that detection of each fluorophore occurred 
only with the correct excitation laser.  
2.6 Antibodies used:  
             Primary antibodies were used at the following concentrations: rabbit anti-Myc 
1:500, goat anti-Myc 1:250, mouse anti-fibrillarin 1:1000 (abcam), guinea pig anti-coilin 
1:2000 (ovaries, embryos, the antibody was a gift from Joseph Gall) and 1:500 (larvae), 
rabbit anti-Lsm11 1:2000 (ovaries and embryos, gift from Joseph Gall) and 1:500 
(larvae), mouse anti-GFP 1:500 (Covance), chicken anti-GFP (abcam) and mouse MPM-
2 1:1000 (Millipore).  
2.7 Epifluorescence Microscopy:  
            Embryos were mounted in SlowFade Gold with DAPI (Invitrogen), and imaged 
using a Motic BA400 compound microscope, Lumen 200 Illumination Systems epi-
fluorescence, Spot Cooled CCD monochrome camera and software. We photographed all 
embryos with identical bulb intensity and acquisition settings 
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2.8 Confocal Micscroscopy:  
             Images were generated using a Zeiss LSM 710 or Olympus FluoView FV1000 
confocal microscope. Images were acquired such that there were no saturated pixels, with 
minimal offset. Modifications to images were minor, and limited to gamma adjustment 
and contrast adjustments within the Olympus FV1000 software.  Modified images were 
cropped using Adobe Photoshop. 
2.9 Northern Blotting for miRNA:  
      Total RNA was extracted using TRIzol (Invitrogen). Approximately 10μg of total 
RNA was heated at 90
o
C for 3 mins and electropheretically separated through a 15% 
urea-polyacrilamide gel at 125V for 2hr. RNA was transferred electrophoretically to a 
nitrocellulose membrane at 4
o
C for 2 hr. RNA was crosslinked by UV radiation and the 
membrane was baked at 80
o
C for 30 min. Probe for let-7 was designed for the mature 
sequence. Let-7antisense probe was radiolabeled by incorporation of [α
-32P
]dATP 6000 
Ci/mmol as recommended bythe vendor. Membrane was hybridized with the let-7 probe 
for 24 h at 42°C in 7%SDS, 0.2MNa2PO4, pH 7.2, and washed twice with 2X SSPE 
0.1% SDS, and once with 1X SSPE 0.1% SDS, and 0.5X SSPE0.1% SDS at 42°C. The 
radioactive signals of let-7 transcripts were quantified by using a PhosphorImager.  
 
 
 
 
 
   
 
CHAPTER 3: SU(Z)2 ANTAGONIZES MYC AUTOREPRESSION 
 
  
3.1 Su(z)2 upregulation results in loss of autorepression by Myc 
As previously discussed, the myc gene undergoes autoregulation under higher 
Myc protein levels. In Drosophila embryos, ectopic expression of dmyc leads to a 
general widespread repression of nearly 200 genes including the Drosophila myc (dmyc) 
gene. Polycomb (Pc) is required for this repression; upon Polycomb depletion by RNAi, 
autorepression by myc is abrogated leading to restoration of normal levels of myc 
transcripts (Goodliffe, Wieschaus et al. 2005). One explanation for the possible role of 
Polycomb is that it is directly involved in the repression of the dmyc gene. Since 
Polycomb is a known chromatin binding repressor, we hypothesized that Polycomb 
physically occupies the dmyc locus and leads to its repression under high Myc protein 
levels. However, this hypothesis is inconsistent with some of our previous data indicating 
that Pho, the protein required for the physical targeting of Polycomb to chromatin, is 
dispensable for Myc autorepression. If Polycomb directly represses the dmyc gene, then 
our Pho RNAi data should have been identical to the Polycomb RNAi data. Since this 
was not the case, we considered an alternate hypothesis.  
We hypothesized that the role of Polycomb in myc autorepression is largely 
indirect; in that, it is required to repress a certain target(s) that can interfere with the 
mechanism of myc autorepression. If our hypothesis is true then it follows that Polycomb
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 RNAi leads to the loss of Polycomb protein, followed by the derepression of a certain 
gene(s) product, whose increased abundance can then abrogate myc
autorepression. Therefore, our Polycomb RNAi microarray data should show us global 
gene expression changes from which we can identify the possible candidate genes that 
could be involved in the myc autorepression pathway. 
 
Figure 4: A schematic representation of the hypothesis for mechanism of Pc mediated 
Myc autorepression. Pc is required to repress gene Y which can interfere and abrogate 
Myc autorepression 
 
Examining our previous microarray gene expression data, we looked at 
expression changes in some key developmental regulators that are known to be involved 
in gene regulation either functioning directly as a transcription factor or as a part of a 
multi-protein complex. We looked at genes belonging to the Trithorax Group (Trx) and 
Polycomb Group (PcG). Of the 18 genes we analyzed, only one gene, Suppressor of 
Zeste 2 (Su(z)2) showed a significant increase in the expression upon Pc RNAi (Figure 5). 
Levels of Su(z)2 transcripts increased 4 fold in the Pc RNAi embryos compared to the 
wild type. This suggests that Polycomb represses Su(z)2, which is consistent with data 
from other published reports (Ali and Bender 2004; Classen, Bunker et al. 2009).  
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Su(z)2 is a homolog of another PcG protein called PSC. It shares a 200 amino 
acid homology with PSC and two other mammalian proteins Bmi-1 and Mel-18 (Brunk, 
Martin et al. 1991; van Lohuizen, Frasch et al. 1991). Functionally, Su(z)2 is known to be  
 
 
 
 
 
 
 
 
 
 
Figure 5: A candidate Y gene: Log ratios of gene expression of select PcG and Trx group 
genes compared to wild type (Gal4) are shown here in embryos with ectopic Myc(blue), 
ectopic Myc plus Pc RNAi (red) and ectopic Myc plus Pho RNAi (green). Su(z)2 levels 
increase significantly in embryos with ectopic Myc plus Pc RNAi compared to Myc++ 
embryos and hence was chosen as a candidate Y gene for further experiments.   
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a potent transcriptional repressor (Brunk, Martin et al. 1991; Brunk, Martin et al. 1991; 
Bunker and Kingston 1994; Sharp, Abramova et al. 1997). Our finding was intriguing, 
because we did not expect a transcriptional repressor to be involved in suppressing 
repression. Although we were surprised to find Su(z)2 to be the only candidate gene, we 
pursued the possibility that Su(z)2 could be involved in the pathway.  
 Based on our data we hypothesized that Su(z)2 disrupts Myc autorepression and 
Polycomb is required to repress Su(z)2. A schematic representation of the hypothesis is 
depicted in Figure 4. To test the above hypothesis, we obtained flies from the Exelixis 
collection that have an XP insertion at the endogenous Su(z)2 gene (referred to as 
Su(z)2XP from here on) which leads to its overexpression under the influence of a Gal4 
driver. We combined homozygous Su(z)2XP flies on second chromosome with flies 
homozygous for ectopic dmyc on third, whose expression is also driven by a Gal4 driver 
(see Materials and Methods). We obtained embryos that express either ectopic dMyc 
alone or ectopic Su(z)2 alone or both ectopic Myc and Su(z)2 under the control of 
armadillo-Gal4 (arm-Gal4).  
In embryos expressing ectopic dmyc, the levels of endogenous dmyc transcripts 
reduced dramatically compared to that of wild type embryos as seen by RT-PCR. These 
data are consistent with our previous microarray data on embryos expressing ectopic myc. 
In embryos overexpressing both ectopic Su(z)2 and dmyc, the levels of the endogenous 
myc increase significantly (P = 0.036) and are comparable to the levels in wild type 
embryos. This suggests that Su(z)2 clearly interferes with Myc autorepression. As seen in 
Figure 1.3, the levels of endogenous Myc are slightly higher in embryos overexpressing 
both ectopic Su(z)2 and ectopic dmyc compared to that of wild type.  
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Figure 6: Su(z)2 upregulation results in loss of autorepression by Myc. A) RT-PCR 
analysis of endogenous, ectopic and total Myc expression in embryos of four different 
genotypes, which are indicated above each lane (Gal4 = arm-Gal4, Gal4-Myc = armGal4; 
UAS dmyc, Gal4-Su(z)2 = arm-Gal4; Su(z)2XP, Gal4-Myc-Su(z)2 = armGal4;Su(z)2XP; 
UAS dmyc). A 0–21 hour collection of embryos was used for RNA isolation and for all 
subsequent assays. Ras64B was used as a loading control. B) A chartshowing 
endogenous dmyc expression, the average of biological triplicates is plotted with standard 
deviations indicated for four genotypes of embryos. Expression was quantified using 
quantity 1 (Bio-Rad). The blue line denotes a statistically significant change 
inendogenous dmyc levels from Gal4-Myc to Gal4-Myc-Su(z)2.  
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We reason that the combination of ectopic Su(z)2 and dmyc is leading to the induction of 
the endogenous dmyc in addition to the alleviation of the autorepression. This can also be 
seen in the embryos expressing ectopic Su(z)2 alone. The levels of dmyc transcripts in 
these embryos are again slightly higher than those of wild type. We interpret these results 
to mean that wild type cells undergo some degree of auto-repression, which is reduced in 
the presence of Su(z)2, leading to increased dmyc expression.  Therefore, Su(z)2 alone 
seems to be sufficient to alleviate the endogenous myc autorepression or to induce Myc 
expression through an unknown mechanism. These data demonstrate the importance of 
the regulation of Myc regulation, more specifically, dmyc autorepression during 
embryogenesis and the role of Su(z)2 in this pathway. 
 Next, we looked at the dMyc protein expression levels in these embryos to 
support our RT-PCR data. We obtained an antibody from Santa Cruz Biotech that targets 
dMyc. We tested the antibody for its specificity (Figure 7) and found that the dMyc 
protein expression pattern was identical to the fluorescent in-situ hybridization (FISH) 
pattern of dmyc transcripts in wild type embryos (FlyFISH). We used this antibody to test 
for dMyc expression levels in embryos of the four genotypes as shown in Figure 8 
(armGal4; armGal4—UASdmyc; armGal4—Su(z)2XP; armGal4—UASdmyc,Su(z)2XP). 
Embryos expressing ectopic Myc have dramatic reduction in overall Myc protein levels, 
whereas embryos expressing both ectopic Myc and Su(z)2 look identical to wild type 
with regard to Myc levels. These data are consistent with our RT-PCR data showing 
dmyc autorepression both at the transcriptional as well as translational level.  
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Figure 7: dMyc antibody validation: Wild type embryo stained for Myc protein (green) 
exhibits a staining pattern identical to in-situ hybridization of dmyc transcripts in 
similarly staged embryo (courtesy: FlyExpress).  
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Figure 8: dmyc auto-repression reduces total Myc protein levels compared to wild type, 
which is rescued by combining ectopic Myc with ectopic Su(z)2 expression. Similarly 
aged embryos of four genotypes are beside one another, with the genotypes of embryos 
indicated above each column. Anti-Myc staining is green.  
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In addition to the reduction in Myc protein levels, we observed certain other 
physical and morphological abnormalities in the embryos expressing ectopic Myc.  These 
embryos have an aberrant Myc expression pattern which is very different from wild type 
embryos (Figure 9). When observed closely, we could discern that the Myc protein 
expression pattern is highly localized with certain few cells having a lot of Myc whereas 
most of the surrounding cells either lacking or showing very faint signal. One explanation 
could be that the Myc signal seen in these embryos is emanating mostly from the ectopic 
Myc. The arm-Gal4 is a weak driver of expression; as a result, the ectopic Myc levels are 
very low compared to wild type endogenous Myc levels. This small amount of ectopic 
Myc is enough to drive autorepression of endogenous Myc to such a drastic level that the 
embryos expressing the ectopic gene experience an almost complete Myc knockdown 
effect. What is left in these embryos is only the ectopic Myc, but its levels and 
distribution differ greatly from wild type. 
As a consequence of the changes in Myc levels and distribution upon Mycauto-
repression, we observed that most of the embryos do not survive embryogenesis. 
Therefore we used a different driver, Gal4-da.G32, because it allowed more embryos to 
hatch into larvae than the arm-Gal4 driver. With Gal4-da.G32 we were able to see many 
embryos hatch into larvae, but these larvae were very small and they failed to survive 
past 4 days (Figure 10). They behave like wandering third instar larvae but their size is 
comparable to that of first instar. These larvae demonstrate a classic Myc hypomorphic 
phenotype and resemble larvae with Myc knockdown mutation(Pierce, Yost et al. 2008). 
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Figure 9: Aberrant Myc expression pattern and  morphology of Myc++ embryos: Similar 
staged wild type and Myc++ (expressing ectopic Myc) embryos are shown. Myc ++ 
embryos clearly have an aberrant expression pattern compared to the wild type embryos. 
Arrows mark clusters of cells with unusually high levels of Myc.   
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Figure 10: Consequence of Myc autorepression:  
Living larvae of the genotypes shown, all grown at low density, aged 4 days after egg 
laying at room temperature, and photographed simultaneously  
 
 
 
 
 
 
 
In contrast, the embryos expressing both ectopic Myc and Su(z)2 were perfectly 
viable and phenotypically normal. Ectopic Su(z)2 completely rescued the Myc knockout 
phenotype by abrogating Myc autorepression. Taken together, the molecular and the 
phenotypical data demonstrate the effect of the strong Myc autorepression mechanism 
and the role of Su(z)2 in rescuing this phenotype.  
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3.2 General repression by Myc is maintained or possibly enhanced by Su(z)2 
Myc is primarily a transcriptional activator but it is also known to repress certain targets. 
We wanted to test whether ectopic Su(z)2 can interfere with Myc’s ability to repress 
genes other than dmyc. We looked at 6 such targets (Cyp6a8, CG31274, Obp56a, 
CG12868, CG31445, JhI-26) that are known to be repressed during embryogenesis by 
Myc(Goodliffe, Cole et al. 2007). In embryos with ectopic Myc, these targets were 
significantly repressed compared to wild type, as shown in Fig 1.6. Although the overall 
Myc levels in these embryos drops due to autorepression, we reason that the repression of 
these targets by Myc occurs either before or during dmyc autorepression. These targets 
remain repressed in embryos that express both ectopic Su(z)2 and Myc, suggesting that 
Su(z)2 does not affect Myc’s ability to repress its targets.  
Surprisingly, these genes were also repressed in embryos expressing ectopic 
Su(z)2 alone. One possible explanation is that, ectopic Su(z)2 disrupts the endogenous 
myc autorepression leading to slightly higher Myc levels in these embryos compared to 
wild type. This increase in Myc levels could be responsible for the repression of these 
genes. Alternatively, ectopic Su(z)2 could also be directly responsible for the repression 
of these genes. Taken together, our results suggest that Su(z)2 disrupts autorepression by 
Myc but does not affect Myc’s ability to repress its targets.  
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Figure 11: Ectopic Su(z)2 does not interfere with Myc repression of targets other than 
dmyc. A) RT-PCR data showing the expression of six Myc targets of repression in four 
genotypes, as indicated above each column of bands. Total dmyc expression and Ras64B 
expression, a loading and RNA level control, are shown in the bottom two panels. B) The 
average band intensities indicating levels of expression and relative standard deviation 
are plotted for the 8 genes shown in A. Genotypes are indicated along the X axis, and the 
Y axis shows band intensities as quantified by Quantity 1 (Bio-Rad). C) ChIP results 
showing H3K27 tri-methylation of one of the 8 genes shown in A, in the 4 genotypes of 
the experiment. Ras64B is a negative control. 
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 Histone modifications are known to cause or maintain specific transcriptional 
states of genes. Specific covalent modifications are attributed to either activation or 
repression. Trimethylation of lysine 27 on Histone H3 (H3K27me3) is a well defined 
mark of repression which is recognized by PcG complexes and is also known to be found 
at Myc repression targets (Goodliffe, Wieschaus et al. 2005; Goodliffe, Cole et al. 2007). 
We wanted to test whether Su(z)2 influenced the histone methylation status at the Myc 
repression targets. We performed Chromatin Immunoprecipitation (ChIP) to test for the 
enrichment of H3K27me3 mark at the above mentioned Myc repression targets. 
Surprisingly there was no difference in the methylation levels at the 6 genes in all four 
genotypes. Figure 1.7 shows the histone methylation levels at Cyp6a8 (one of the six 
repression targets) and dmyc. We were also surprised to find reduced histone methylation 
levels at dmyc in embryos expressing ectopic Myc. This result was contrary to the 
autorepressiondata seen in Figure 1.3 and 1.4. These data suggest that this embryonic 
chromatin modification, histone H3 trimethylation of lysine 27, does not mediate the 
transcriptional state of Myc repression targets.  
3.3 Activation by Myc is enhanced by Su(z)2: 
As shown earlier, ectopic Su(z)2 abrogates Myc autorepression, leading to 
restoration of overall Myc levels and consequently rescuing the Myc knockdown 
phenotype in larvae. We were interested in determining the basis for this rescue by 
ectopic Su(z)2. We wanted to test whether ectopic Su(z)2 restores the normal Myc 
transcriptional activity by eliminating autorepression. We tested activation by Myc using 
the same system in all four genotypes. We looked at three known Myc targets of  
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Figure 12:  Increased Su(z)2 provides for activation of Myc targets, and a reduction in 
their H3K27 tri-methylation. A) RT-PCR analysis showing expression of three Myc 
activation targets (indicated on the left side of the gel pictures) in embryos of 4 different 
genotypes (indicated above the lanes). B) Average band intensities (Quantity 1) of 
biological triplicates are plotted on the right, with relative standard deviations indicated. 
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activation (CG14147, CG7330, Fzy) (Goodliffe, Cole et al. 2007). In embryos expressing 
ectopic Myc, the expression of all three targets is lower than that of wild type because the 
overall levels of Myc are lower than those of the wild type embryos (Figure 1.8). 
Interestingly, in embryos expressing both ectopic Su(z)2 and Myc, the levels of all three 
genes are higher and similar to the levels in wild type embryos.  This effect likely occurs 
because the Myc levels in these embryos are also comparable to those in wild type 
embryos due to the lack of Myc autorepression.The results are also consistent with these 
targets being Myc responsive; they are activated under normal Myc levels and de-
activated under low Myc condition. This result helps explain the molecular reason behind 
the rescue of the Myc knockdown phenotype. These data suggest that ectopic Su(z)2 
leads to the restoration of endogenous Myc levels that are sufficient enough to perform its 
normal transcriptional activity during embryogenesis.  
3.4 Ectopic Su(z)2 alters histone H3 lysine 27 methylation at Myc activation 
targets: 
Embryonic Myc activation targets are known to be marked by histone H3 lysine 
27 trimethylation(Goodliffe, Cole et al. 2007). We were interested to see whether ectopic 
Su(z)2 can alter the histone modifications at Myc target genes leading to their activation 
by Myc. We performed Chromatin Immunoprecipitation (ChIP) using antibodies against 
H3K27-Me3 to test for the histone methylation status at five known Myc activation 
targets (CG14147,CG7330, Cyp309a2, SamDC and 128up). All of these targets are 
known to be Myc responsive (Goodliffe, Wieschaus et al. 2005; Goodliffe, Cole et al. 
2007); SamDC and 128up are known to have Myc bound at their promoters (Orian, van 
Steensel et al. 2003). Keeping conditions identical to our RT-PCR experiments, we 
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performed ChIP on embryos aged 0-21 hrs. As shown in Figure 1.9, in embryos 
expressing ectopic Myc alone, 4 out of 5 of these targets had higher H3K27  
 
 
 
 
 
 
 
 
 
Figure 13: Su(z)2 alters histone methylation at Myc targets: ChIP assay showing histone 
H3K27 tri-methylation at five Myc activation targets (indicated to the left of the gel 
pictures) in embryos of genotypes indicated on top. Data shown on the left are plotted in 
a stacked column chart; the y-axis is the density of each PCR product divided by the 
density of the input sample PCR product, and the values for each gene are stacked 
together for each of the four genotypes.  
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trimethylation compared to wild type, consistent with their deactivation seen in figure 1.8. 
Embryos expressing both ectopic Su(z)2 and Myc, show reduced H3K27 methylation at 
these targets similar to that in wild type embryos. Interestingly, embryos expressing 
ectopic Su(z)2 alone showed reduced histone methylation compared to wild type at 3 out 
of 5 of these targets. These data are consistent with our RT-PCR data showing the 
expression levels of Myc activation targets. The data also correlate well with the Myc 
levels in these four genotypes, suggesting that low Myc levels influence increased 
methylation of these targets leading to deactivation and conversely, higher Myc levels 
cause activation of these targets through a reduction in the histone methylation. 
3.5 Discussion: 
Su(z)2 is a chromatin binding repressor that belongs to Polycomb Group related 
complexes. It is a functional homolog of PSC, a PcG protein present in the PRC1 
complex (Lo, Ahuja et al. 2009). Su(z)2 and PSC are known to share a set of common 
targets, exhibiting a degree of evolutionary redundancy in their function. This is evident 
by the abnormal bristle phenotype caused by the overexpression of either of these 
genes(Brunk, Martin et al. 1991; Sharp, Martin et al. 1994). PSC and Su(z)2 are also 
known to co-localize at many loci on polytene chromosome (Rastelli, Chan et al. 1993; 
Sharp, Abramova et al. 1997). Deletion of the PSC-Su(z)2 region causes hyper-
proliferation in the wing imaginal disc whereas clones homozygous mutant for either of 
the two genes are normal, suggesting again the redundancy in the function of these two 
genes (Beuchle, Struhl et al. 2001). 
Recently, it has been shown that Su(z)2 co-precipitates with the components of 
the PRC1 complex. Also, the authors demonstrated that Su(z)2 can replace PSC in a 
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functional PRC1 complex in-vitro but Su(z)2 has a lower DNA binding affinity than 
PSC(Lo, Ahuja et al. 2009). Taken together, these findings may provide a rationale for 
the observed role of Su(z)2 in the abrogation of Myc autorepression. One hypothesis is 
that ectopic Su(z)2 can replace PSC in the PRC1 complex, thereby rendering the complex 
ineffective. This hypothesis may only hold true if the PcG complexes are directly 
involved in the repression of the dmyc locus. In embryos with ectopic Su(z)2, the high 
levels of Su(z)2 protein could compete with and replace the endogenous PSC from the 
PRC1 complex. Although, PSC and Su(z)2 can be redundant, the high levels of Su(z)2 
protein in these embryos could possibly produce many non-functional complexes with 
other PcG components which could interfere or compete with the functional complexes. 
Since Su(z)2 has lower DNA binding affinity, the PRC1 complex with Su(z)2 could be 
ineffective in the repression of the dmyc locus in embryos with ectopic Myc and Su(z)2. 
This hypothesis could also help explain the fact that although Polycomb is required for 
Myc autorepression, ectopic Su(z)2 can eliminate Myc autorepression even in the 
presence of Polycomb.  
Our results show that ectopic Su(z)2 can derepress Myc but does not affect 
repression by Myc, suggesting that Su(z)2 works in different mechanisms in these two 
situations. It is interesting to note that a repressor is interfering with Myc repression. 
Therefore we have not ruled out the possibility that Su(z)2 could be involved in a more 
indirect manner. It is possible that Su(z)2 represses another gene(s) that could be 
involved in the regulation of Myc transcription and that Polycomb is required to maintain 
low levels of endogenous Su(z)2 during early embryogenesis. 
 39 
Su(z)2 has two mammalian homologs: Bmi-1 and Mel-18(van Lohuizen, Frasch 
et al. 1991; Sharp, Abramova et al. 1997). Bmi-1 and Mel-18 share the same homology 
region with PSC and Su(z)2, suggesting that they belong to an evolutionary gene family 
with similar molecular functions. However, Bmi-1 and Mel-18 are known to exhibit 
opposite roles in the progression of cancer. Mel-18 acts as a tumor suppressor by 
repressing c-Myc and Bmi-1 whereas Bmi-1 is known as a proto-oncogene (Guo, Zeng et 
al. 2007; Wiederschain, Chen et al. 2007). Bmi-1 was isolated as a collaborator of Myc in 
tumorigenesis (Haupt, Alexander et al. 1991; van Lohuizen, Verbeek et al. 1991). Our 
findings demonstrate an interesting function for Su(z)2 whereby it can upregulate Myc 
transcription suggesting a potentially co-operating role in Myc induced growth and 
proliferation. However, Su(z)2 has also been shown to be a tumor suppressor gene 
(Classen, Bunker et al. 2009).Knowing the conflicting roles of Su(z)2, it becomes 
imperative to ask one important question here: Is Su(z)2 a functional homolog of Bmi-1 
or Mel-18? It would be interesting to pursue further experiments to determine the precise 
role of Su(z)2 during development. One hypothesis is that the roles of PSC and Su(z)2 
are very context specific. Su(z)2 behaves largely as a tumor suppressor by regulating the 
expression of proto-oncogenes, suggesting that it is similar to Mel-18 but Su(z)2 can also 
switch roles to promote growth under special conditions as seen in our experiments. For 
future studies, it would very be interesting to study the broader evolutionary context of 
this functional dimorphism exhibited by Su(z)2. 
 
CHAPTER 4: ROLE OF LET-7 miRNA IN REGULATIONOF DMYC 
 
 
4.1: Let-7 miRNA could be required for Myc autorepression: 
 
Overexpression of c-Myc causes tumorigenesis via a widespread repression of 
miRNAs, along with the upregulation of many other targets. The let-7 family was 
identified as one of the groups of miRNAs repressed by c-Myc(Chang, Yu et al. 2008; 
Chang, Zeitels et al. 2009). However, c-Myc does not repress let-7 miRNAs 
transcriptionally, but rather it inhibits their maturation by a post-transcriptional 
mechanism that involves the activation of Lin28B, an RNA binding protein(Chang, 
Zeitels et al. 2009).Lin28B is directly activated by c-Myc, and is responsible for the 
inhibition of miRNA biogenesis. Lin28B inhibits the Drosha and Dicer mediated 
processing of let-7 miRNA by binding to the let-7 primary transcript (Newman, Thomson 
et al. 2008; Rybak, Fuchs et al. 2008; Viswanathan, Daley et al. 2008). Interestingly, the 
let-7 family of miRNAs is known to be strong tumor suppressor, inhibiting the translation 
of many oncogenes, one of which is c-Myc (Esquela-Kerscher, Trang et al. 2008; Roush 
and Slack 2008; He, Chen et al. 2010). This is a positive feedback mechanism by which 
c-Myc activates Lin28B that blocks the processing of let-7 and consequently prevents the 
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down-regulation of c-Myc by let-7.  
Drosophila has a single let-7 gene which is known to be important for 
metamorphosis from larval to pupal stages (Caygill and Johnston 2008). Let-7 is induced 
by the expression of ecdysone, a steroid hormone required for metamorphosis (Sempere, 
Dubrovsky et al. 2002).The timing of let-7 expression is critical to ensure normal 
development. It’s expression begins during the late third instar larval stage and continues 
during the pupal stages, reaching a peak on the second day of the pupal life (Sempere, 
Dubrovsky et al. 2002). Interestingly, the expression of dMyc inversely correlates with 
the expression of let-7(modENCODE). dMyc expression peaks at larval L1 stage and 
drops dramatically during late L3 stage. The levels continue to remain low throughout the 
pupal and adult life. Like its mammalian homolog, it is possible that Drosophilalet-7 
could repress dMyc. The high levels of dMyc during the larval stages could act as a 
systemic signal to trigger the process of metamorphosis by inducing let-7. The induction 
of let-7 in turn, represses dMyc, slowing growth and proliferation and initiating 
metamorphosis. Therefore, we hypothesized that let-7 mediates the process of Myc 
autorepression in our model.    
To test the hypothesis, we performed a preliminary genetic cross with flies 
heterozygous for a deficiency spanning the let-7 locus. Along with let-7, the locus 
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contains few other annotated genes. Nevertheless, we went ahead to perform a 
preliminary test. If let-7 is required for Myc autorepression, then deletion of let-7 should 
abrogate autorepression leading to the rescue of the autorepression phenotype. The cross 
is illustrated above. We combined flies heterozygous for the deficiency with homozygous 
UAS-dMyc on the third chromosome. We then crossed these flies to flies carrying the da-
Gal4 driver. All embryos resulting from this cross express ectopic dMyc. As shown in the 
schematic above, the cross yielded two classes of progeny. Only flies with the Df 
chromosome survived whereas none of the embryos with the Cy chromosome survived 
past larval L1 stage.  The surviving flies express both endogenous and ectopic Myc, as 
seen by RT-PCR (Figure 14). As a consequence of ectopic dMyc expression, the embryos 
undergo autorepression and as shown in our earlier experiments, these embryos do not 
survive past the larval stages. However, embryos that are heterozygous for the deficiency 
are perfectly viable. They progress through normal life cycle to reach adulthood without 
any discernable phenotypic abnormalities. On the contrary, embryos with the SM6 
balancer chromosome, which has a dominant marker (Cy), exhibited the autorepression 
phenotype and died as 2
nd
 instar larvae. These data suggest that let-7 could be required to 
induce Myc autorepression. However, since the deficiency encompasses other genes 
along with let-7, we cannot be certain that let-7 is the only gene responsible for this 
rescue.  
 
4.2: Let-7 miRNA is upregulated in embryos undergoing Myc autorepression: 
In the embryos expressing ectopic Myc, the levels of dMyc are higher than a 
threshold that is normal for embryogenesis. The sum total of endogenous Myc and 
ectopic Myc could potentially mimic the levels found during the L3 stage. We 
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hypothesize that this abundance of Myc triggers the premature expression of let-7 during 
embryogenesis and consequently, leads to the down-regulation of endogenous Myc. 
However, the untimely and uncontrolled expression of let-7 leads to such a dramatic 
knockdown of Myc that the organism fails to progress through normal development due 
to the lack of endogenous Myc. To test this hypothesis we looked at the expression of let-
7 miRNA by Northern Blot analysis. Our results indicate that let-7 miRNA is expressed 
in embryos with ectopic Myc but not in wild type embryos, as expected. Let-7 transcript 
levels are absentin wild type embryos (negative control), elevated in embryos with 
ectopic Myc, and highin the two positive controls: let-7 overexpressing embryos and 
adult flies (Figure 15A).  
4.3 let-7 does not repress Myc unlike its mammalian homolog: 
To test whether let-7 miRNA represses dMyc, we obtained transgenic flies that 
contain a UAS-let-7 sequence on the second chromosome (a gift from Dr. Laura 
Johnston).  To induce the ectopic expression of let-7 we crossed the UAS-let7 flies to 
flies with the da-Gal4 driver. The expression of the let-7 miRNA in the resulting embryos 
was validated by Northern Blot as seen in Figure 15. Initial q-PCR analysis revealed that 
dMyc is down-regulated in embryos overexpressing let-7 (Figure 15B). The expression of 
Myc levels in this experiment were normalized to Ras64B, a control gene used for 
normalizing in all of our previous experiments.  
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Figure 14: Df(36E6-37B1) lacking the let-7 gene rescues Myc autorepression phenotype: 
A) Percentage of surviving progeny from the cross. 0 embryos carrying the Cy 
chromosome survived whereas 90% of embryos with the Df chromosome survived to 
adulthood (n=30). Student t-test shows p<0.001. B) RT PCR showing expression of 
endogenous and ectopic Myc in surviving flies with the Df chromosome.   
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Figure 15: Let-7 expression in embryos undergoing autorepression: A) Northern Blot 
analysis for small RNA showing let-7 miRNA expression in positive controls (adult flies, 
let-7 overexpressing embryos), wild type embryos (negative control) and embryos with 
ectopic Myc (Myc++). B) q-RT PCR analysis showing relative quantification of 
endogenous Myc expression in wild-type (control) and let-7 overexpressing embryos (let-
7++). The expression of Myc was normalized to Ras 64B.    
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Figure 15C: Ras64B is upregulated in let-7++ embryos: RT PCR analysis showing 
Ras64B, used as a normalizing gene in the Qrt-PCR experiment in B, is upregulated in 
Let-7++ embryos whereas Myc levels do not change.  
 
 
The expression of Ras64B did not change in any of our previous experiments. However, 
gel electrophoresis analysis following conventional RT-PCR showed that the levels of 
Ras64B were elevated in embryos overexpressing let-7 (Figure 15C). We repeated this 
experiment numerous times by quantifying and normalizing the total RNA content in 
each sample and found that Ras64B was significantly higher in let-7++ embryos 
compared to wild type. These data nullify the q-PCR results we obtained earlier since the 
Myc levels were normalized to Ras64B. The Myc levels do not change in let-7++ 
embryos compared to wild type embryos Therefore, we found that Drosohpila let-7 
miRNA, unlike its mammalian homolog, does not repress dMyc.  
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4.4 Discussion:  
Regulation of Myc is critical to ensure normal growth and development. One way 
to achieve this precise regulation is by employing miRNAs that ensure the fine-tuning of 
Myc levels based on the developmental context. MiRNAs are a class of genes that help 
regulate protein concentration of a gene product in the cell by binding to and preventing 
the translation of its mRNA. Let-7 is an evolutionarily conserved gene family known to 
initiate differentiation, metamorphosis and inhibit proliferation(Johnson, Esquela-
Kerscher et al. 2007; Caygill and Johnston 2008; Sokol, Xu et al. 2008). In humans, the 
let-7 family consists of ten different isoforms of which let-7a is known to inhibit Myc 
translation. Overexpression of Myc leads to direct transactivation of Lin28B which 
inhibits the maturation of let-7a miRNA. This positive feedback loop as depicted in the 
figure earlier demonstrates a mechanism by which Myc levels can be controlled during 
cellular growth. Unlike mammals, Drosophila has a single let-7 gene whose onset of 
expression coincides with the decline of dMyc expression during development. Also, let-
7 is required for differentiation and metamorphosis, both of which are inhibited by Myc.  
Therefore, we thought it is logical tohypothesize that a similar mechanism of Myc 
regulation could occur during Drosophila embryogenesis and development. However, 
our data suggests that let-7 miRNA does not repress dMyc regardless of the 
developmental context. The decline in Myc expression during late L3 stages and 
coincidentally the onset of let-7 expression could be mutually exclusive phenomena 
regulated by different mechanisms.  
One interesting observation that can be made from our results is the induction of 
let-7 in the ectopic Myc expressing embryos. These embryos undergo autorepression and 
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consequently have very low levels of endogenous Myc. It is intriguing to note that let-7 is 
being induced in these embryos since let-7 is only expressed after the L2 stage. One 
possible explanation for this premature expression could be due to the dramatic decrease 
in endogenous Myc. Contrary to our initial hypothesis that the induction of let-7 in the 
autorepression embryos is due to the ectopic overexpression of Myc, we postulate that 
let-7 induction is a consequence of Myc autorepression and not a cause. The decrease in 
endogenous Myc causes a systemic trigger in the organism to stop proliferation and 
initiate differentiation and as a consequence, leads to the induction of let-7 miRNA.  
 Another interesting observation is the phenotypic rescue obtained using the 
Df(36E6-37B1) deficiency flies. The cytological locus 36E6-37B1 is a 600MBregion 
which encompasses 30 other annotated genes. It is possible that any one of these genes, 
other than let-7, could be involved in the Myc autorepression pathway. Performing an 
RNAi screen for individual genes could help narrow down potential candidate genes 
involved in Myc regulation. Alternatively, two or more of these genes could act 
coordinately in a direct or indirect manner to regulate Myc expression. In any case, we 
have identified a list of 30 genes that are required for regulation of Myc levels.  
We hypothesize that there could be many other factors that are required for the 
regulation of Myc levels during embryogenesis. One way to test this hypothesis is by 
performing a genome wide genetic screen using the Drosophila deficiency kit which has 
about 400 fly lines with overlapping deficiencies spanning the entire genome. 
 
CHAPTER 5: MYC LOCALIZES TO HISTONE LOCUS BODIES 
 
5.1 Myc rarely localizes to nucleolus 
 
During our preliminary antibody staining experiments to observe Myc expression 
in embryos, we noticed distinct Myc spots in certain tissues (Figure 16). We were curious 
about the identity of these puncta. Myc protein binds to the ribosomal DNA and 
stimulates the transcription of rRNA genes by RNA polymerase I in mammalian cells 
(Arabi, Wu et al. 2005; Grandori, Gomez-Roman et al. 2005). Unlike its mammalian 
homolog, dMyc is not found to be present at the rRNA genes (Grewal, Li et al. 2005), 
however high Myc levels are correlated with the increased size of nucleolus (Marinho, 
Casares et al. 2011). Nonetheless we began investigating the identity of these spots by 
double staining different tissues with antibodies against Myc and Fibrillarin, a nucleolar 
marker (Figure 17).  
Myc was largely excluded from the nucleolus in all the tissues we tested. In the 
nurse cells of the ovaries, we observed many Myc spots in the nuclei but these rarely 
overlapped with fibrillarin, suggesting that Myc is not present in nucleolus (Figure 17B). 
In the follicle cell nuclei, we failed to observe any distinct Myc spots, although we did 
observe general Myc staining. Similarly Myc was largely excluded from the nucleolus in 
the salivary gland nuclei. However, in embryos, we did observe Myc overlap with 
Fibrillarin in a few cells (Figure 17 A), although in most cells, the spots of Myc and 
Fibrillarin were clearly distinct. 
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Figure 16: Myc protein forms distinct puncta in certain tissues. Stage 10/11 
embryoimmunostained for Myc (green) and Dapi (blue). Bottom panel is a zoomed in 
picture of the orange box in the head region of the embryo. The arrows point at the Myc 
spots in the cells of the head region.   
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Figure 17A: Myc rarely localize to nucleolus: A stage 10 embryo labeled with Myc 
(green), fibrillarin (red) and DAPI (blue) showing minimal overlap of Myc and fibrillarin 
(bottom three panels, note the cell within the yellow circles with a bright fibrillarin 
domain that lacks Myc). 
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Figure 17B: Myc rarely localizes to nucleolus: Myc (green), fibrillarin (red) and DAPI 
label stage 8 (top) and 10 (lower) egg chambers. Arrows label a nurse cell, and 
arrowheads label a follicle cell.
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Although Fibrillarin is a strong nucleolar marker, it is also known to be present in sub-
nuclear organelles called Cajal Bodies (Liu, Murphy et al. 2006). The overlap observed 
with Myc and Fibrillain in embryos and to a certain extent in salivary glands coincided 
with Cajal Bodies and not the nucleolus (see below).  
5.2 Myc co-localizes with Coilin 
Cajal Bodies (CB) are dynamic sub-nuclear organelles that are involved in the 
assembly and processing of small nuclear ribonucleoproteins (snRNPs) before they are 
exported to chromosomes for splicing (Nizami, Deryusheva et al. 2010). They are 
transient and dynamic bodies frequently occurring adjacent to the nucleolus. They are 
identified by the presence of a signature protein called coilin. Coilin is required for the 
nucleation and integrity of the CBs. In Drosophila and Arabidopsis, coilin null tissues 
lack CBs. Coilin knockout mice have serious fecundity and fertility defects and are semi-
lethal(Liu, Wu et al. 2009; Walker, Tian et al. 2009). Cultured cells from coilin-knockout 
mice lack functional CBs and show the presence of ―residual‖ bodies containing some of 
the components of CBs (Tucker, Berciano et al. 2001). Since we saw a minimal overlap 
of Myc with fibrillarin, we hypothesized that Myc localizes to the CBs. We double 
stained tissues with antibodies against Myc and coilin.  
 In nurse cells of ovaries, Myc and coilin localized to the same bodies. Myc spots 
almost always contained coilin (49 of 50 Myc bodies contained coilin), although less than 
half of Cajal Bodies contained Myc (21 of 57 CBs contained Myc). In follicle cells of the 
ovary, we did not see any Myc spots. In salivary gland nuclei, Myc spots colocalized with 
most of the large coilin bodies (22 of 27 coilin bodies).  
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Figure 18A 
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Figure 18: Myc co-localizes with coilin: A) A stage 6 embryo labeled with Myc (green), 
fibrillarin (red), coilin (white) and DAPI, showing that locations where Myc and 
fibrillarin overlap are punctacontainingcoilin (shown by the white arrow in the higher 
magnification boxes below). Myc does not overlap with fibrillarin in the nucleolus 
(shown by the orange arrow). B)A stage 9 egg chamber labeled with Myc (green) and 
coilin (orange). The light gray arrow points to a nurse cell, and arrowhead points to a 
follicle cell. A nurse cell lacking overlap of Myc with coilin is shown (nurse cell in the 
green boxes, panels below and left), and a nurse cell with Myc and coilin containing 
puncta is also shown (nurse cell in the light gray boxes, panels below and right).  
Figure 18B 
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In embryos, Myc puncta start to appear post-cellularization, and following their 
occurance in the cellular blastoderm, Myc puncta always overlapped with coilin (75 Myc 
positive CBs, n=78). Myc puncta were also found to overlap coilin in the cells of 
postblastoderm mitotic domains (39 Myc positive CBs, n=41 CB). During later stages, 
Myc appeared diffuse in most cells of endoderm and we could not discern any Myc spots. 
However, in the cells of ectoderm and the head region, Myc puncta were seen to overlap 
coilin (32 Myc positive CBs, n=37CB).These data indicate that Myc protein appears in a 
coilin containing body; it could be either a Cajal Body or a Histone Locus Body (HLB) of 
which coilin is also a component. Next we tested whether Myc and coilin are components 
of HLBs or CBs.  
5.3 Myc and Coilin localization occurs mainly in HLBs 
The HLB is a dynamic sub-nuclear organelle similar to the Cajal body but is 
always associated with the histone gene loci and hence the name, Histone Locus Body. It 
is marked by the presence of U7snRNP which is required for the processing of histone 
Mrna(Godfrey, Kupsco et al. 2006; Nizami, Deryusheva et al. 2010). CBs and HLBs can 
reside next to each other and both can contain coilin. Since we found Myc puncta positive 
for coilin, we investigated if these pucta were HLBs rather than CBs. We obtained 
transgenic flies expressing an HLB marker, Lsm11-EYFP (gift from Dr. Gall) under the 
control of Gal4. Lsm11 is the protein component of U7snRNP and is specific for HLBs 
(Godfrey, White et al. 2009).  We induced the expression of Lsm11-EYFP and triple 
stained embryos with anti-gfp, anti-Myc and anti-coilin. We also stained wild type larvae 
and ovaries with anti-Lsm11 (gift from Dr. Gall), anti-Myc and anti-coilin.  
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Figure 19A: Myc and coilin overlap occurs only in HLBs: A wild type, stage 8-9 embryo 
labeled with Myc (green), coilin (red), Lsm11-EYFP (white) and DAPI (blue) showing 
that Myc, coilin and Lsm11 co-localize to the majority of the bodies occurring in these 
embryos (lower panels show the cells in the orange box). 
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Figure 19B: Myc and coilin overlap occurs only in HLBs: Two egg chambers, ,stages 5-6, 
labeled as indicated and showing that Myc, coilin and Lsm11 co-localize in nurse cells 
and the oocyte nucleus (the arrow labels a nurse cell and arrowhead labels a follicle cell; 
the oocyte nucleus is within the light blue dashed circle). The panels on the right show a 
nurse cell with Myc, coilin and Lsm11 in the same bodies; a nurse cell lacking Myc in a 
coilin-Lsm11 body; the oocyte with all three co-localized (right panels). 
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In nurse cell nuclei, Myc overlapped with coilin and Lsm11. Immunostaining salivary 
glands with anit-Myc and anti-GFP or anti-Lsm11 showed Myc localization to HLBs. 
81% of Lsm11 and coilin positive HLBs contained Myc (n=27). Myc was rarely seen in 
bodies positive for coilin but lacking Lsm11. Only 20% of non-Lsm11 CBs contained 
Myc. These data suggest that Myc is only present in HLBs. In embryos, Myc puncta were 
almost always positive for Lsm11 and coilin suggesting that majority of embryonic 
bodies are HLBs (in 221 Myc punta 208 also contained Lsm11 and coilin).  
5.4 Myc localizes to HLBs only during replication: 
Because many different cell types showed Myc in the HLB, however not uniformly 
within an egg chamber or embryo, we investigated whether Myc localization to HLBs is 
cell cycle dependent. We stained embryos, larvae and ovaries with the monoclonal 
antibody MPM-2, which cross-reacts with phosphoepitopes of mitotic cells in many 
organisms. In Drosophila embryos, MPM-2 recognizes the 59 hosphor-epitope of a 
protein present in HLBs, but only in cells with active Cyclin E/Cdk2. We first examined 
all coilin-containing bodies, which may be CBs or HLBs, by staining embryos with 
MPM-2, anti-coilin and anti-Myc antibodies. Myc appeared in 100% of the coilin and 
MPM-2 positive bodies, n= 30. Myc appeared in just 10% of CBs or HLBs lacking 
MPM-2, n =30. We found similar results in ovaries, that Myc overlapped MPM-2 in all 
nurse cells containing puncta positive for MPM-2 (n = 30 nurse cells), and overlap with 
coilin was limited to MPM-2 positive bodies (all of which are HLBs later in oogenesis.  
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Figure 20: Myc localizes to HLBs in replicating cells. A) A stage 10 egg chamber is 
shown, labeled with Myc (green), coilin (red), MPM-2 (white) and DAPI, and a nurse 
cell is labeled with the light gray arrow. Myc, coilin and MPM-2 overlap in the HLB of 
the nurse cell in the yellow boxes, and MPM-2 and Myc overlap although coilin staining 
is weak in the HLB of the nurse cell in the gray boxes.  
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Figure 20B) A stage 8 egg chamber, labeled with Myc (green), MPM-2 (red), Lsm-11 
(white) and DAPI shows that Myc puncta are the HLBs of replicating nurse cells. A nurse 
cell is shown with MPM-2 positive HLBs (cell in yellow boxes and magnified below), 
and Myc appears in those HLBs. A nurse cell is shown with Lsm11, non-MPM-2 staining 
HLBs, and Myc is absent (cell in light gray boxes, magnified below in the right-most 
panels). 
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Figure 21: Quantification of Myc foci: A chart showing the numbers reported in the text 
of Myc-overlapping (green bars) and non-Myc-overlapping puncta containing coilin (C), 
Lsm11 (L), and MPM-2 in embryos (E and the third and fifth sets of bars), larvae (L) and 
nurse cells (NC and also the fourth set of bars). 
 
 
To examine bodies identifiable as HLBs in cells undergoing replication, we 
stained ovaries and embryos with MPM-2, anti- Lsm11 (or anti-GFP) and anti-Myc. Myc 
and Lsm11 co-localized only in the presence of the MPM-2 epitope. HLBs containing 
bothLsm11 and MPM-2 were positive for Myc. HLBs lacking the MPM-2 epitope also 
lacked Myc. In embryos, replicating cells were identified with MPM-2 positive HLBs, 
and those bodies always included Myc (n= 27). Myc was never observed in MPM-2 
negative HLBs, n= 33.  
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Discussion:  
In our study we find that Myc localizes to HLBs. What is the function of Myc in 
HLB? Since Myc is a transcription factor it is logical to assume that it is required for 
histone gene transcription. However, with the discovery of Mxc in HLB, does it mean 
that Myc assumes a secondary role in transcription or is Myc involved in processing? 
Could it be possible that there are multiple tissue specific transcription factors required 
for histone gene transcription? White and others have shown that Mxc is required for 
HLB assembly and function in a cell-autonomous manner. So what then is the role of 
Myc in HLB? Is Myc required for HLB assembly? We conducted some preliminary 
experiments to address this question. From the initial results, it seems that Myc is not 
required for HLB formation. We tried transient knockdown of Myc in larval salivary 
glands and embryos by crossing flies with a UAS-MycRNAi construct to a hsGal4 driver; 
however, the Myc knockdown model was found to be highly inconsistent and hence we 
are not certain of the conclusion. A better system would be to use S2 cells and induce 
transient Myc RNAi and assess HLB formation and also histone gene transcription. This 
system can also be used to assay for histone mRNA processing as well. This would give 
us a better picture if Myc is involved in transcription or processing or both.  
Another possible avenue of investigation would be the mode of Myc localization 
to HLB during S phase. Does dMyc get phosphorylated by a G1/S specific kinase to 
facilitate its localization to HLB? Although, c-Myc is known to be phosphorylated at S62 
by CycE/Cdk2, this residue is not conserved in dMyc. It is possible that there could be 
other sites that are phosphorylated by Cdk2 during G1/S transition and hence it causes 
localization to HLB. 
 
CHAPTER 6: SIGNIFICANCE AND FUTURE DIRECTION 
 
 
In this chapter I will attempt to give the reader a measure of the overall 
significance of both my projects and a general perspective of how this study could be 
helpful in advancing the prevailing understanding of these fields. Both the projects probe 
the basic functions of Myc as a transcription factor. While the HLB project merits further 
investigation based on the sheer novelty of the findings, the autorepression project bears 
great potential in identification of factors involved in regulation of Myc expression in 
normal development and tumorigenesis. A general concern is the translation potential of 
these findings in the Drosophila model to the mammalian model. Functional studies in 
Drosophila have been shown to be able to translate into human model because of the 
evolutionary conservation of the biological activity of important genes such as Myc. 
Hence, my work here could be used as a template for further investigation both in 
Drosophila as well as human cell culture models.  
6.1 Myc Autorepression: Significance: 
In this study I found that Myc autorepression occurs in the cells expressing an 
ectopic Myc gene resulting in the down regulation of the endogenous dmyc locus. This 
phenomenon requires Pc; since Pc represses Su(z)2, knockdown of Pc results in 
upregulation of Su(z)2 and the abundance of Su(z)2 leads to disruption of Myc 
autorepression via an unknown mechanism. In tumorigenic mammalian cells, Myc
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autorepression is lost, leading to increased Myc protein levels that can cause increased 
proliferation, transformation and immortalization of cells. Therefore, this project is 
significant because of the identification of a factor that can cause disruption of Myc 
autorepression and increase Myc expression. However, the precise mechanism or the 
factors that contribute to the induction and loss of Myc autorepression in tumorigenic 
cells is still unknown.  
One hypothesis is that because of ectopic Myc expression, the Myc protein levels 
reach a critical concentration that leads to the activation of a gene(s) or pathway that is a  
 
direct repressor of the endogenous Myc locus. This could be achieved either at 
transcriptional level or post-transciptional level, depending on the nature of the gene 
activated. High levels of Myc can induce a miRNA that has a seed sequence 
complementary to endogenous Myc. Therefore, activation of such a miRNA could lead to 
downregulation of dmyc transcripts and protein. One such miRNA has been identified in 
Drosophila. The miRNA-308 is a direct target of Myc and is only induced at high Myc 
protein levels (Kaveh Daneshvar, personal communication). This miRNA has been 
shown to bind to endogenous Myc transcripts and inhibit translation to a great extent. 
However, overexpression of the miRNA alone in embryos does not phenocopy Myc 
autorepression, suggesting that repression mechanism by the miRNA is very modest and 
is not sufficient to create a Myc null phenotype.  
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On the other hand, this could be possible if high Myc levels activate a gene or a 
pathway that can lead to transcriptional silencing of the endogenous dmyc locus. One 
such pathway has recently been identified that could shed some light on the 
autorepression mechanism (Kaur, M and Cole, MD 2012). The authors noticed that Myc  
 
repression targets, including the endogenous Myc promoter, have elevated H3K27Me3 
mark. Upon investigation, they found that this was due to increased stability of the 
histone methyltransferase Ezh2. The stability of Ezh2 is regulated by Akt by 
phosphorylation of a conserved serine 21 residue. Akt is inhibited by phosphorylation at 
serine 473 by PTEN. The authors have shown that upon ectopic Myc expression, Myc 
transactivates PTEN, a bona fide Myc activation target. PTEN causes deactivation of the 
Akt kinase by phosphorylating Akt at S473, thereby leading to increased Ezh2 protein 
which methylates H3K27 at Myc repression targets including the myc promoter leading 
to the transcriptional downregulation of these genes.  
To understand how Myc autorepression is lost in cells that have an ectopic myc 
gene or how the expression of Myc is maintained at low levels in a terminally 
differentiated cell, we have to identify the pathway(s) that control Myc expression. In the 
study mentioned above, the authors have shown that the PTEN/Akt pathway is activated 
ectopic Myc gene expression. In my study I have identified Su(z)2 as a component of an 
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unknown pathway that can prevent the repression of dmyc locus. Since Su(z)2 is a 
transcriptional repressor, it is logical to propose that Su(z)2 represses a repressor (―X‖) of  
 
 
Myc. Su(z)2 could repress a direct transcriptional repressor of Myc or act more upstream 
of the pathway that has many intermediaries that have a cumulative effect of Myc 
repression. In that case, the ―X‖ here could represent more than one gene.  Based on the 
new evidence, a new hypothesis is that Su(z)2 represses PTEN or any component of that 
pathway resulting in depletion of Ez protein levels that cause H3K27 demethylation at 
dmyc locus. Our results show that in the presence of ectopic Su(z)2, Myc activation 
targets have low levels of H3K27 trimethylation. This could be due to a decrease in Ez 
activity which suggests that excess Su(z)2 inhibits the PTEN/Akt/Ez pathway. 
Alternatively, Su(z)2 could also repress miRNA-308 which regulates Myc post-
transcriptionaly.   
 Su(z)2 has been shown to be a strong suppressor of growth and proliferation via 
the inhibition of the Jak-Stat pathway. However, in the context of Myc autorepression, I 
have found that Su(z)2 promotes growth via the depression of dmyc gene. These 
conflicting roles could be due to the difference in developmental context. The two 
mammalian homologs of Su(z)2, Mel-18 and Bmi-1, have opposite roles in tumorigenesis. 
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While Mel-18 is a tumor suppressor known to repress c-myc, Bmi-1 is a direct 
transactivation target of Myc known to cooperate in Myc induced tumorigenesis. 
However, neither of these genes has been shown to induce Myc expression either in a 
cancer model or c-myc autorepression model. Which of these two homologs is Su(z)2 
most similar to in terms of its role in the regulation of Myc? To address this question I 
propose some future experiments that could help us understand the evolutionary function 
of Su(z)2 and its mammalian homologs in regulation of Myc. 
6.2 Future direction: 
To understand the role of Su(z)2 in Myc autorepression and tumorigenesis, it 
would be interesting to see if it can abrogate c-myc autorepression in mammalian cell 
culture model. If overexpression of Su(z)2 under the c-myc autorepression genetic 
background model leads to depression of the c-myc locus then that would suggest that  
this pathway is evolutionarily conserved. By overexpressing either Bmi-1 or Mel-18 
under the same genetic background and analyzing depression of c-myc as a readout, we 
could infer if Su(z)2 acts as Mel-18 or Bmi-1in this context.  
If the autorepression pathway in conserved then we could use our genetic model 
in flies because of the simplicity of the genome to identify factors involved in the 
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pathway. One way to identify new factors in a pathway is by performing a genetic screen 
to look for modifiers of the phenotype caused due to the genetic background of the model. 
I propose to conduct a genetic screen by making use of the deficiency kit available 
through the stock center.As shown in the figure we will cross flies carrying the ectopic 
myc gene to flies that are heterozygous for a deficiency (Df) on either the 2
nd
 or 3
rd
 
chromosome. The deficiency is a deletion that can range from a few kilobases to a few 
megabases on one of the homologous chromosomes. These deletions are mapped to their 
precise cytological and sequence coordinates. The fly stock center at Bloomington 
maintains fly lines that have overlapping deletions that span entire chromosomes.In order 
to control the expression of the ectopic myc gene we will make use of the Gal4-Gal80 
system. Upon shifting to 29
0
C, the embryos exhibit mycautorepression phenotype that 
results in larval lethality due to the induction of the ectopic myc gene. We will cross 
these flies to the flies that are heterozygous for a deficiency (Df) and transfer them to 
29
o
C incubator. Flies with the Df also have a GFP balancer chromosome. As shown in 
the figure this cross will yield two categories of progeny; 
1) carrying the deficiency (Df) chromosome along with a copy of ectopic myc ---(test 
group---rescue?) and  
2) a copy of ectopic myc and GFP balancer chromosome. (control group—autorepression 
phenotype) 
I propose to use all the deficiencies in the 2nd and 3rd chromosome available through the 
Bloomington stock center. 
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6.3 Myc in HLB: Significance: 
In my study I have shown that Myc localizes to HLBs during replication or S 
phase. This is a novel finding with regard to Myc’s biological activity. Although, we’re 
not yet certain of Myc’s role in HLBs during replication, a rational hypothesis is that it is 
involved in transcription of the replication dependent histone genes. Histone genes are 
transcribed and processed during S phase. During replication, a cell requires new histones 
to incorporate into the duplicated genome. Proper transcription and processing of histones 
is essential to maintain genomic integrity during cell division. This project is significant 
because of its novelty and its implication in maintenance of genetic integrity. However, 
many questions still remain unanswered with regard to the overall impact of this finding. 
Some of the important ones are concerning the role of Myc in histone transcription and 
processing. Is Myc required for histone transcription or processing or both? Does Myc 
directly activate histone transcription or is it required only to modify chromatin by 
recruiting other cofactors? How is Myc localization to HLB coordinated? Does Myc 
require phosphorylation by a kinase to facilitate its localization? c-Myc is known to be a 
Cdk2 substrate for phosphorylation. Does dMyc also get phosphorylated by Cdk2? 
Alternatively, it is also possible that Myc has no role in histone gene transcription or 
processing and that its localization to HLB is a means to sequester the nuclear Myc 
protein to HLB during replication and mitosis.  
6.4 Myc in HLB: Future Direction: 
To address some of the questions mentioned above I propose some follow up 
studies that would be helpful in understanding the importance of Myc in HLBs. First, to 
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understand the role of Myc in HLB, it is essential to analyze histone gene transcription in 
Myc mutants or Myc RNAi background. The histone locus is a cluster of repeats of a  
 
 
Single unit of the 5KB Drosophila histone gene repeat 
 
 
5KB region that contains the core histone genes. The H3/H4 gene pair is separated by a 
300nt region, as in the H2A/H2B gene pair. The intergenic region between H3 and H4 
contains information necessary for HLB formation and histone gene transcription of both 
H3/H4 and H2A/H2B gene pairs (Robert Duronio, personal communication). Therefore, 
the 300nt between H3 and H4 must contain sequences that are recongnized by specific 
transcription factors. It would be interesting to see if this region has an E-box. Myc 
binding to this region can be tested by performing a ChIP experiment. If Myc binds to 
this region, then it can be inferred that it does aid in histone transcription. Does Myc play 
a role in histone mRNA processing? A simple northern blot analysis for any of the 
histones can answer this question. Using probes for mature, processed histone H3 mRNA 
we can test this is wild type and Myc mutant background to check if histone processing is 
affected upon Myc knockdown. How is Myc localization to HLB during S phase 
achieved? Does Myc get phosphorylated by a kinase? To address this, we have to 
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conduct mutational analysis by expressing deletion mutants of Myc in cells and test for 
its localization to HLBs as readout. Once we identify a deletion mutant that fails in 
localization, we can narrow down the putative phosphorylation sites in that domain. By  
 
Figure 22: Mechanism of Myc localization to HLB: The cartoon depicts possible 
mechanism of Myc localization to HLB during S Phase.  
 
mutating individual amino acid residues in that domain, we can test for the localization of 
full length Myc to HLBs. This can tells us definitively as to which amino acids get 
phosphorylated.  
My findings in both these projects have far reaching implications with respect to 
Myc function in maintenance of genomic integrity and regulation of Myc induced growth 
and proliferation. With the discovery of Myc in HLB we have shown that Myc plays 
many important and diverse roles in a cell and hence it is a critical player in controlling 
vital cellular processes.   
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